SALIX PHARMACEUTICALS INC
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for SALIX PHARMACEUTICALS INC NOTE 2.750% 5/1, CUSIP 795435AC .
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for SALIX PHARMACEUTICALS INC NOTE 2.750% 5/1, CUSIP 795435AC .